This inventor holds 1 USPTO granted patent, plus 3 CIPO patents. Top assignee: Synthon B.v.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Theodorus Hendricus Peters: Innovator in Pharmaceutical Chemistry
Introduction
Theodorus Hendricus Peters is a notable inventor based in Arnhem, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating depression. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving mental health treatments.
Latest Patents
One of Theodorus Hendricus Peters' key patents is for 4-Phenylpiperidine compounds for treating depression. This invention relates to a compound and pharmaceutically acceptable salts, characterized by a specific formula. The compound includes variations where R represents an alkyl or alkynyl group with 1-4 carbon atoms, or a phenyl group that may be substituted by various functional groups. This patent highlights his commitment to addressing mental health issues through innovative chemical solutions. He holds 1 patent.
Career Highlights
Theodorus has built a career at Synthon B.V., a company known for its focus on developing complex pharmaceuticals. His work at Synthon has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovation.
Collaborations
Throughout his career, Theodorus has worked alongside notable colleagues such as Franciscus Bernardus Benneker and Frans Van Dalen. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Theodorus Hendricus Peters stands out as an influential inventor in the realm of pharmaceutical chemistry. His dedication to creating effective treatments for depression through innovative compounds is commendable. His work continues to inspire advancements in mental health therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
